Literature DB >> 29714430

Reliability and validity of the Turkish Nose Obstruction Symptom Evaluation (NOSE) scale

Serdar Karahatay, Hamdi Taşlı, Ömer Karakoç, Ümit Aydın, Türker Türker.   

Abstract

Background/aim: The aim of this study was to validate the Turkish Nasal Obstruction Symptom Evaluation (T-NOSE) scale. Materials and methods: The NOSE scale was translated into Turkish. A prospective study was conducted involving adult subjects with nasal obstruction and a control group. The patients were divided into three groups, namely nasal septum deviation (NSD), septoplasty, and control groups. Internal consistency, test-retest reliability, validity, responsiveness, and the magnitude of the effect of surgery were all investigated.
Results: In total, 253 subjects were enrolled in the study. Cronbach’s alpha was 0.938 and 0.942 upon test and retest, respectively, which proved good internal consistency. The mean kappa value was 0.82, indicating a high level of reproducibility. The difference between postoperative and control groups was not statistically significant (P < 0.05). The T-NOSE score of the NSD group was 65.67 ± 16.77, while it was 10.75 ± 12.25 for the control group (P < 0.01). The mean score improved following septoplasty (P < 0.001). The magnitude of the effect of surgery was considered high. The correlation between the visual analogue scale and NOSE scores was 0.948.
Conclusion: The T-NOSE scale is a valid instrument with good internal consistency, reliability, reproducibility, validity, and responsiveness.

Entities:  

Keywords:  NOSE; Turkish NOSE; validation

Year:  2018        PMID: 29714430     DOI: 10.3906/sag-1509-81

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  2 in total

1.  Powered Micro-saw Versus Conventional Osteotome for Septorhinoplasty: A Prospective, Double-Blind, Comparative Study.

Authors:  Gözde Pamuk; A Erim Pamuk; Süheyla Kandemir
Journal:  Aesthetic Plast Surg       Date:  2022-09-09       Impact factor: 2.708

2.  Omalizumab is effective in nasal polyposis with or without asthma, a real-life study.

Authors:  Tuğba Songül Tat
Journal:  World Allergy Organ J       Date:  2022-08-10       Impact factor: 5.516

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.